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Abstract 
Background: The rise of antimicrobial resistance has been described as a 
threat to human health. Judicious use of antimicrobials, through 
antimicrobial stewardship (AMS) is a key component of the World Health 
Organization’s Global action plan on antimicrobial resistance. AMS 
programs involve multiple strategies to ensure optimal antimicrobial 
selection, dosage, route of administration and duration of therapy to 
maximise the benefit of antimicrobials, whilst minimising the associated 
collateral damage. Although AMS has been a requirement for hospital 
accreditation in Australia since 2013 implementation and evaluation of AMS 
in Australian tertiary paediatric hospitals has been limited by the 
complexities in the patient population, and the local infrastructure and 
resources.  
Aim: Evaluate an AMS program in an Australian tertiary paediatric hospital  
Methods: The Centers for Disease Control and Prevention core elements 
of AMS for hospitals provided a framework for six studies, two studies 
focused on the use of the local computerised decision support and approval 
system (CDSS). The CDSS was assessed as an intervention to reduce 
inappropriate broad-spectrum antibiotic use for community-acquired 
pneumonia, compliance with the CDSS and its utility as a tracking tool were 
explored in a second study. Educational needs of nursing and non-
consultant medical staff were determined using two different survey 
approaches. Candidate units of measure for antimicrobial surveillance were 
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developed and used to evaluate the impact of AMS in the paediatric 
intensive care setting in a quasi-experimental design study. 
Results: Children with suspected uncomplicated community-acquired 
pneumonia were predominantly prescribed guideline-concordant narrow-
spectrum penicillins at admission to hospital both before and after CDSS 
implementation. CDSS use was uncommon after standard pharmacy and 
AMS working hours, with ongoing implications for AMS involvement the 
next standard working day. Broad-spectrum antibiotics, potentially suitable 
for long term trend analysis were identified. Both standard adult defined 
daily doses and vial-based estimates did not identify an association 
between implementation of the CDSS and a reduction in restricted antibiotic 
use.
